Trump Withdraws Controversial Surgeon General Pick, Announces Third Nominee

In a dramatic political development, Donald Trump has withdrawn his controversial nominee for U.S. Surgeon General and announced a third candidate for the role—marking a significant shift in his administration’s public health leadership strategy.
Withdrawal of Casey Means Nomination
Trump officially pulled the nomination of Casey Means, a wellness entrepreneur and prominent supporter of the “Make America Healthy Again” (MAHA) movement. Means’ nomination had been stalled for months due to mounting bipartisan concerns, including:
Questions about her medical credentials and lack of active clinical practice
Scrutiny over her views on vaccines and public health policies
Resistance from key lawmakers, especially Republican Senator Bill Cassidy, who chairs the Senate Health Committee
Ultimately, her nomination failed to gain enough support to move forward in the Senate confirmation process.
Trump Names Third Pick: Nicole Saphier
Following the withdrawal, Trump announced Nicole Saphier as his new nominee for U.S. Surgeon General. A radiologist at Memorial Sloan Kettering Cancer Center A former Fox News medical contributor Known for advocating preventive healthcare and cancer screening Unlike Means, Saphier is viewed as having more conventional medical credentials, which could improve her chances of Senate confirmation.
A Third Attempt at Filling the Role
This marks Trump’s third nomination for the nation’s top doctor: Janette Nesheiwat (withdrawn earlier) Casey Means (now withdrawn) Nicole Saphier (current nominee) The repeated changes highlight the political sensitivity surrounding public health leadership, especially amid ongoing debates over vaccines and healthcare policy.
Political Tensions and MAHA Movement
The controversy also reflects deeper divisions tied to the MAHA movement, closely associated with Health Secretary Robert F. Kennedy Jr.. Means was seen as a strong ally of Kennedy’s agenda Critics argued her views aligned too closely with anti-establishment health positions Saphier, while supportive of some MAHA goals, is considered more mainstream and politically viable
What Happens Next?
Saphier’s nomination will now move to the Senate, where lawmakers will evaluate her qualifications and policy positions. Stabilize leadership in U.S. public health Signal a shift toward a more confirmable, less controversial approach Influence the future direction of national health messaging
Trump’s decision to withdraw Casey Means and nominate Nicole Saphier underscores the complex intersection of politics, medicine, and public trust. After two failed attempts, the administration appears to be recalibrating—prioritizing credibility and Senate approval over ideological alignment.

